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To understand geographic variation in travel-related 
illness acquired in distinct African regions, we used the 
GeoSentinel Surveillance Network database to analyze 
records for 16,893 ill travelers returning from Africa over a 
14-year period. Travelers to northern Africa most commonly 
reported gastrointestinal illnesses and dog bites. Febrile 
illnesses were more common in travelers returning from 
sub-Saharan countries. Eleven travelers died, 9 of malaria; 
these deaths occurred mainly among male business trav-
elers to sub-Saharan Africa. The profile of illness varied 
substantially by region: malaria predominated in travelers 
returning from Central and Western Africa; schistosomiasis, 
strongyloidiasis, and dengue from Eastern and Western 
Africa; and loaisis from Central Africa. There were few re-
ports of vaccine-preventable infections, HIV infection, and 
tuberculosis. Geographic profiling of illness acquired during 
travel to Africa guides targeted pretravel advice, expedites 
diagnosis in ill returning travelers, and may influence desti-
nation choices in tourism.
Africa is a popular tourist destination and a focus for international aid work, research, and business travel. 
In 2011, compared with 2010, international arrivals on the 
African continent remained relatively stable at ≈50 mil-
lion, although the number of travelers to northern Africa 
decreased by 1.7 million (9%) and travel to sub-Saharan 
Africa increased by 1.3 million (4%) travelers (1). Identifi-
cation of the types and relative frequencies of illnesses ac-
quired by travelers to Africa would enable targeted preven-
tion strategies before and during travel, as well as diagnosis 
and management of illness in returnees.
Previously described as “the Dark Continent,” refer-
ring to poor knowledge of its interior, Africa’s diverse 
geography, ecosystems, and climate are now well defined. 
However, detailed understanding is lacking about the vari-
ety of illnesses experienced by travelers who visit different 
parts of this diverse continent. Prior studies have focused 
on travel-related illnesses acquired only within sub-Saha-
ran Africa (2) or have concentrated on a single infection (3). 
The perception of the public and health care practitioners is 
that the risk of acquiring many travel-related illnesses, in-
cluding malaria, is uniform throughout the continent. This 
misconception was particularly evident to practitioners of 
travel health in South Africa before the 2010 Fédération 
Internationale de Football Association World Cup in South 
Africa, an annual event that attracts hundreds of thousands 
of persons to the hosting country. This erroneous concept 
and a need for evidence-based travel advice prompted a 
GeoSentinel study that demonstrated marked variation in 
morbidity rates for malaria, African tick bite fever, and oth-
er travel-related illnesses in persons returning from South 
Regional Variation in Travel-related 
Illness acquired in Africa,  
March 1997–May 2011
Marc Mendelson, Pauline V. Han, Peter Vincent, Frank von Sonnenburg, Jakob P. Cramer,  
Louis Loutan, Kevin C. Kain, Philippe Parola, Stefan Hagmann, Effrossyni Gkrania-Klotsas,  
Mark Sotir, and Patricia Schlagenhauf, for the GeoSentinel Surveillance Network1
RESEARCH
532 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 20, No. 4, April 2014
Author affiliations: University of Cape Town Groote Schuur Hospital, 
Cape Town, South Africa (M. Mendelson); Centers for Disease 
Control and Prevention, Atlanta, Georgia, USA (P.V. Han, M. Sotir); 
Tokai Medicross Travel Clinic, Cape Town (P. Vincent); University of 
Munich, Munich, Germany (F. von Sonnenburg); University Medical 
Center, Hamburg-Eppendorf, Germany (J.P. Cramer); University of 
Geneva, Geneva, Switzerland (L. Loutan); University of Toronto, 
Toronto, Ontario, Canada (K.C. Kain); Assitance Publique Hôpitaux 
de Marseille– North University Hospital, Marseille, France (P. Parola); 
Yeshiva University Bronx-Lebanon Hospital Center, Bronx, New 
York, USA (S. Hagmann); Cambridge University Hospitals National 
Health Service Trust, Cambridge, UK (E. Gkrania-Klotsas); and 
University of Zurich Centre for Travel Medicine, Zurich, Switzerland 
(P. Schlagenhauf)
DOI: http://dx.doi.org/10.3201/eid2004.131128
1Contributing members of the GeoSentinel Surveillance Network 
are listed at the end of this article.
 Travel-related Illness, Africa
Africa compared with persons returning from neighboring 
countries or other countries in sub-Saharan Africa (4). The 
objective of the current analysis is to study regional varia-
tion in travel-acquired and emerging infections across Af-
rica. Reaching this objective will better inform pretravel 
clinical consultations, which will help travelers recognize 
illnesses in the travel destination, take preventive measures, 
and seek treatment; and will focus differential diagnoses by 
clinicians among travelers returning from Africa.
Methods
The GeoSentinel Surveillance Network (www.istm.
org/geosentinel/main.html) is an international network of 
specialized travel and tropical medicine providers housed in 
sites in 23 countries on 5 continents, established through the 
International Society of Travel Medicine (www.istm.org/) 
and the Centers for Disease Control and Prevention (www.
cdc.gov). Details of patient recruitment, structure, and func-
tion of GeoSentinel sites that systematically report on all ill 
travelers have been described (2). Data for ill travelers are 
collected during or after travel. Demographics, travel his-
tory, reason for travel, clinical symptoms, and diagnostic 
information are recorded anonymously on a questionnaire, 
and GeoSentinel sites enter the information into a central 
database. The best available reference diagnostic tests are 
used at each site to categorize illness into 1 of 23 syndromic 
groups and >500 individual diagnoses. Representatives from 
the sites enter each diagnosis as laboratory confirmed or 
probable; both are included in the analysis. The country or 
region of illness acquisition is identified on the basis of itin-
erary, known endemicity patterns, and incubation periods.
To study regional variation in the pattern of illnesses in 
persons who traveled to Africa, we used the United Nations 
geoscheme to classify Africa into subregions: Eastern, Cen-
tral, Northern, Southern, and Western Africa (Figure 1) (5). 
An ill traveler returning from a country within an African 
region was considered to have been exposed to the caus-
ative pathogen in that region if the GeoSentinel database 
had a record of its occurrence there; or if the exposure was 
not defined in the record but the ill person traveled only to 
countries within that region. We included in our study all ill 
travelers listed in the GeoSentinel database during March 
14, 1997–May 31, 2011 (Figure 2).
Statistical Analysis
Demographic and travel characteristics of travelers to 
each African region were described by using frequencies 
and proportions for categorical variables and median and 
range for continuous variables. Analysis of Plasmodium 
falciparum malaria trends during 2007–2011 was calcu-
lated on the basis of monthly counts of ill returned travel-
ers with febrile systemic illness that were aggregated over 
the study period. Of 54 sites in the GeoSentinel database 
reporting during 2007–2011, a total of 35 sites reported 
consistently during this period. We used only data from 
those 35 sites for trend analysis. Data were analyzed by 
using SAS version 9.2 (http://support.sas.com/software/92/
index.html).
Results
We identified 16,893 ill travelers who returned from 
a single country or multiple countries within the same 
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Figure 1. Regions of Africa as 
defined by the United Nations 
geoscheme (5). For persons 
whose country of exposure was 
unascertainable or missing but 
for whom all recent travel was to 
the same region of Africa, data 
were included in the final dataset. 
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region in Africa during a 14-year period. Most acquired 
their illness either in Western (35%) or Eastern Africa 
(33%). Illness associated with travel to Southern Africa 
(8%) was least frequently reported (Figure 2).
Patient Characteristics
Most ill travelers returning from all regions were 18–64 
years of age (Table 1). The residence of travelers spanned 
72 countries; travelers were most frequently from Germany 
(33%), United States (12%), Canada (11%), France (10%), 
and Switzerland (10%).
Male travelers more commonly visited Central and 
Western Africa, and female travelers were more likely 
to visit Eastern and Northern Africa. Travelers visiting 
friends or relatives (VFR) more commonly visited Central 
(29%) and Western (33%) Africa than the other regions 
(2%–11%). Business travelers more frequently traveled to 
Central Africa (32%) than to other regions (9%–16%). Ap-
proximately three quarters of travelers to Northern (74%) 
and Southern Africa (78%) were tourists. Travelers to 
Northern Africa were less likely to have had a pretravel 
medical consultation (35%) than were travelers to other 
regions (50%–61%). Posttravel hospitalization rates were 
higher in travelers to Central and Western Africa (21%–25%) 
than in travelers to Northern and Southern Africa (5%–11%). 
The most frequent diagnoses among hospitalized travelers 
were P. falciparum malaria (45%), P. vivax malaria (4%), 
and unspecified febrile illness (<3 weeks) (3%).
Deaths among Travelers to Africa
Deaths of 11 travelers were recorded after travel to re-
gions of sub-Saharan Africa (Table 2). Ten were of male 
sex; 10 were adults (median age 50 years). Severe P. falci-
parum malaria predominantly acquired in Western Africa 
was the cause of death for 9 of the 11 travelers. Two deaths 
occurred in expatriates, and 6 male business travelers died 
of P. falciparum malaria.
Northern Africa
Travel to Northern Africa was predominantly char-
acterized by acquisition of gastrointestinal illnesses, com-
prising 66% of the 16,893 travel-related illnesses from this 
region and 7 of the 10 most frequent diagnoses (Table 3). 
In contrast, gastrointestinal disorders from regions of sub-
Saharan Africa represented 27%–40% of cases. There was 
no difference among regions for acute or chronic diarrhea, 
schistosomiasis, or other gastrointestinal disorders such 
as intestinal strongyloidiasis. Of the reported hepatitis A 
cases, 28 (47%) originated in Northern Africa. Analysis of 
the data for individual countries in the Northern Africa re-
gion did not show variation in type of diarrheal disease or 
gastrointestinal disease (data not shown).
Documentation of animal bites and the need for ra-
bies postexposure prophylaxis (PEP) showed striking geo-
graphic variation. Of the 193 reports of bites on the conti-
nent, 23% were to travelers <18 years of age. Of the 184 
who received rabies PEP, 21% were travelers <18 years of 
age. Travelers to Northern Africa accounted for 105 (54%) 
of the 193 bites from dogs, cats, and others (including mon-
key and human) reported in Africa (Table 4); in contrast, 
16 (8%) bites were reported from Southern and Central Af-
rica combined. Similarly, 107 (58%) of the 184 exposures 
requiring rabies PEP were reported from Northern Africa. 
Although Egypt was the most commonly visited country in 
Northern Africa (3 times the number of visits to Morocco), 
travelers to Morocco received the most bites (21 dog bites, 
8 cat, 3 other).
Regions within Sub-Saharan Africa
In contrast to the vast numbers of reports of gastroin-
testinal disease, febrile illnesses were uncommon in trav-
elers to Northern Africa (4%). Conversely, 11%–47% of 
travelers returning from regions of sub-Saharan Africa had 
a febrile illness (Table 5). P. falciparum malaria was the 
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Figure 2. Flowchart for analysis of ill returned travelers from Africa 
reported in the GeoSentinel Surveillance Network, March 1997–
May 2011. The United Nations geoscheme was used to classify 
Africa into subregions (5).
 Travel-related Illness, Africa
most common cause of fever in returning travelers from 
sub-Saharan Africa, a finding consistent with those of pre-
vious studies (6,7). Of travelers who had malaria, 47% 
were VFR. Of travelers returning with malaria, 6% were 
<18 years of age. The proportion of febrile illness caused 
by malaria differed among regions: 2% of travelers return-
ing from Southern Africa with febrile illness had malaria, 
compared with 69% and 67%, respectively, from Western 
and Central Africa. Conversely, African tick bite fever was 
the leading cause of illness in 273 (47%) of 579 travelers 
with fever returning from Southern Africa.
P. falciparum was the most common cause of malar-
ia from all regions, including 100% of identified malaria 
cases from Southern Africa. P. vivax was proportionately 
more common from Eastern Africa (8%) than from other 
regions (0%–4%), and most of P. ovale and P. malariae 
cases were acquired in Central or Western Africa. Interre-
gional seasonal variation in malaria acquisition was noted, 
although Western Africa was the only region that had a rec-
ognizable pattern of malaria cases, which the GeoSentinel 
sites reported more frequently from July through January.
A previous GeoSentinel study identified schistosomi-
asis as the most frequent helminthic infection reported in 
travelers returning from Africa, with regional variation not-
ed (8). Seventy-three percent of reported strongyloidiasis 
cases were acquired in travelers returning from Eastern and 
Western Africa; 3% were reported in travelers to Southern 
Africa (Table 4). Acquisition of Strongyloides stercoralis 
from previous travel to, or birth in, other countries to which 
this infection is endemic cannot be discounted. Loasis ac-
counted for 86 of 236 filarial infections, 82 (94%) of which 
were acquired from Central Africa, consistent with known 
endemicity; 50 (62%) of the 82 were from Cameroon, 12 
from Gabon, 10 from Central African Republic, and 3 from 
Congo. Female travelers (58%) were more often infected 
by Loa loa than were men; volunteers (45%) and travelers 
VFR (30%) were the groups most often affected. Only 10% 
of cases were seen in tourists. Although largely an infection 
diagnosed in adults, 8% of cases were diagnosed in children 
(median age 10 years [interquartile range 7.0–16.5 years]).
Vaccine-preventable infections (VPI; i.e., hepati-
tis A, influenza, measles, and Salmonella typhi infection 
[typhoid]) taken together accounted for 0.9% of illnesses 
in travelers returning from Africa. The proportion of VPI 
from each region was comparable (Table 4). Among de-
mographic groups, tourists were most likely to have VPI, 
most commonly hepatitis A and typhoid acquired in North-
ern Africa. Sex distribution was equal, and apart from 17 
(29%) of the 59 hepatitis A cases that occurred in travelers 
<17 years of age, most VPI were diagnosed in adults. The 
acquisition of a VPI was not related to whether a pretravel 
consult had been sought.
During the 14-year study period, 86 cases of symp-
tomatic tuberculosis were diagnosed in travelers returning 
from Africa, and an additional 159 travelers had positive 
tuberculin skin tests. Whether the positive skin tests were 
caused by acquisition of infection during travel or by prior 
exposure is unknown because no records of pretravel test 
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Table 1. Characteristics of ill travelers returning from Africa who were seen at GeoSentinel clinic sites, March 1997–May 2011* 
Characteristic 
No. (%) travelers by region 
Total,  
N = 16,893 
Central Africa, 
n = 1,547 
Eastern Africa, 
n = 5,516 
Northern Africa, 
n = 2,474 
Southern Africa, 
n = 1,457 
Western Africa, 
n = 5,899 
Sex       
 M 8,698 (52) 922 (60) 2,582 (47) 1,126 (46) 723 (50) 3,345 (57) 
 F 8,130 (48) 615 (40) 2,909 (53) 1,344 (54) 733 (50) 2,529 (43) 
Age, y       
 Median (range) 35 (0–92) 37 (0–92) 34 (0–89) 37 (0–87) 40 (0–87) 35 (0–84) 
  ≤5 364 (2) 27 (2) 79 (1) 72 (3) 12 (1) 174 (3) 
  6–17 553 (3) 31 (2) 147 (3) 109 (4) 36 (2) 230 (4) 
  18–49 12,172 (72) 1,145 (75) 4,059 (74) 1,638 (67) 936 (64) 4,394 (75) 
  50–64 2,869 (17) 282 (18) 900 (16) 471 (19) 324 (22) 892 (15) 
  >65 853 (5) 52 (4) 304 (6) 170 (7) 147 (10) 180 (3) 
Expatriate 1,066 (6) 276 (18) 315 (6) 54 (2) 22 (2) 399 (7) 
Travel reason       
 Business 2,710 (16) 490 (32) 797 (14) 211 (9) 187 (13) 1,025 (17) 
 Volunteer 2,438 (14) 310 (20) 975 (18) 139 (6) 77 (5) 937 (16) 
 Student 419 (2) 29 (2) 162 (3) 14 (1) 28 (2) 186 (3) 
 Tourism 7,914 (47) 254 (16) 2,932 (53) 1821 (74) 1128 (78) 1,779 (30) 
 VFR† 3,304 (20) 442 (29) 622 (11) 276 (11) 34 (2) 1,930 (33) 
Hospitalized 2,718 (16) 319 (21) 628 (12) 264 (11) 71 (5) 1,436 (25) 
Died 11 (<1) 3 (<1) 2 (<1) 0 0 6 (<1) 
Sought pretravel advice‡       
 Yes 8,752 (52) 775 (50) 3,387 (61) 860 (35) 875 (60) 2,855 (48) 
 No 4,721 (28) 383 (25) 1,172 (21) 1,038 (42) 345 (24) 1,783 (30) 
 Don’t know 3,420 (20) 389 (25) 957 (17) 576 (23) 237 (16) 1,261 (21) 
*Values are no. (%) unless otherwise indicated. The United Nations geoscheme was used to classify Africa into subregions (5). 
†VFR, visiting friends or relatives. 
‡Sought advice from clinician pertaining to recognition of illnesses in travel destination, preventive measures, and treatment. 
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results are available. Travelers returning from Central and 
Southern African regions, which are among countries with 
the highest rates of tuberculosis worldwide (9), accounted 
for 6 cases of symptomatic tuberculosis (Table 4).
Acute HIV infection was recorded for 44 persons. As 
was the case for tuberculosis, the number of acute HIV in-
fections from Central and Southern Africa was lower than 
that from Eastern and Western Africa. No cases were diag-
nosed in travelers to Northern Africa.
Dengue is a common cause of illness in travelers to the 
Asia–Pacific region and Latin America (2); however, in our 
study, dengue acquired in Africa was diagnosed in as few 
as 113 travelers with febrile illness during the 14-year study 
period. Our data suggest that 81% of cases were acquired 
during travel to either Eastern or Western Africa (Table 4). 
Dengue was diagnosed equally in both sexes, and infection 
in travelers 18–49 years of age accounted for 81% of cases. 
Tourists were the major risk group for this illness.
Discussion
Our study provides an evidence base of regional in-
fectious disease exposures among travelers returning from 
Africa. These data show a profile of travel-related illness 
that differs with that of resident populations in these re-
gions; this knowledge is essential in prioritizing preven-
tive measures for the approximately 50 million travelers to 
Africa each year. Diarrheal and other gastrointestinal ill-
nesses, hepatitis A, dog bites, and a very low proportion 
of febrile illnesses characterized the health of travelers re-
turning from Northern Africa. In contrast, febrile illnesses 
were the predominant cause of clinic visits in travelers 
returning from sub-Saharan Africa, although considerable 
differences were evident in the etiology of fever in travelers 
from different regions. Malaria, which was most common 
in travelers returning from Central and Western Africa, was 
seen infrequently in travelers to Southern and Northern 
Africa. The incidence of helminthic infections also varied 
considerably: schistosomiasis and strongyloidiasis pre-
dominated in travelers returning from Eastern and Western 
Africa, but 82 of 86 L. loa infections reported in this study 
were diagnosed in travelers returning from Central Africa 
(Table 4). HIV infection and tuberculosis dominate the in-
cidence of disease for much of sub-Saharan Africa and are 
an increasing concern for travelers, but our results show 
that these infections were rarely diagnosed in travelers at 
GeoSentinel Sites (Table 4).
Several factors likely contributed to our observations. 
Certain illnesses related to travel in Africa are more com-
mon in particular demographic groups. For instance, ma-
laria is more common in travelers VFR than in tourists 
(9). In our study, malaria-related deaths occurred most 
often in men who traveled for business, a finding that may 
have implications for companies with expanding business 
interests in Africa. Pretravel medical advice and use of 
effective malaria prevention measures and chemoprophy-
laxis are essential for business travelers to areas of risk. 
Quantifying malaria risk is difficult, but the regional pro-
files presented here in which malaria predominated as a 
diagnosis are useful indicators (Tables 3, 5). High rates of 
malaria in Western and Central Africa reflect high malaria 
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Table 2. Deaths of ill travelers returning from Africa who were seen at GeoSentinel clinic sites, March 1997–May 2011* 
Patient no. Age, y/sex Diagnosis Region Exposure country Travel reason Expatriate 
1 66/M Malaria, Plasmodium 
falciparum. Severe and 
complicated, noncerebral 
Western Burkina Faso Business No 
2 68/M Malaria, P. falciparum. Severe 
and complicated, cerebral 
Eastern Kenya Tourism No 
3 50/M Malaria, P. falciparum. Severe 
and complicated, cerebral 
Western Ghana Business Yes 
4 61/M Malaria, P. falciparum. Severe 
and complicated, cerebral 
Western Sierra Leone Business No 
5 4/M Pneumonia, bacterial, lobar Eastern Tanzania, Accompanying parent 
on business 
No 
6 48/M Malaria, P. falciparum. Severe 
and complicated, cerebral 
Western Ghana VFR No 
7 47/M Mycobacterium tuberculosis, 
pulmonary and 
extrapulmonary 
Western Unknown VFR No 
8 57/M Malaria, P. falciparum. Severe 
and complicated, cerebral 
Western Liberia Missionary/volunteer/ 
researcher/aid worker 
No 
9 30/F Malaria, P. falciparum. Severe 
and complicated, cerebral 
Central Equatorial Guinea Business Yes 
10 53/M Malaria, P. falciparum. Severe 
and complicated, noncerebral 
Central Angola Business No 
11 40/M Malaria, P. falciparum. Severe 
and complicated, cerebral 
Central Angola Business No 
*Three patients with malaria who died did not receive chemoprophylaxis, 1 received mefloquine, and data were missing for the remaining 5 travelers. The 
United Nations geoscheme was used to classify Africa into subregions (5). VFR, visiting friends or relatives. 
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transmission levels in these areas. Entomologic inocula-
tion rates (the number of infectious mosquito bites that 
a person receives in a certain time period) are a useful 
indicator of malaria risk. For example, the entomological 
inoculation rate for Bayma in Sierra Leone (Nov 1990–
Oct 1991) was 884, compared with 1.5 for Kilifi Town in 
Kenya during the same period (10).
For some infections, such as the helminthic infections 
loaisis and onchocerciasis, vector distribution affects ac-
quisition. Seasonal and climatic factors and degree of en-
demicity influence the likelihood of malaria and dengue 
transmission, whereas food and water hygiene, along with 
differences in sanitation, influence acquisition of diarrheal 
diseases. Illnesses that are commonly self-limiting and of-
ten have mild symptoms, such as influenza and dengue, are 
less likely to result in a visit to a clinic. Furthermore, travel-
ers in a sub-Saharan Africa country who have fever may be 
examined by clinicians who will treat them empirically for 
malaria and thus misdiagnose another infection.
The finding that travelers were rarely seen in GeoSen-
tinel site clinics for VPI, irrespective of the region visited, 
extends previous observations from Southern Africa (4) 
and remains a paradox, considering that rates of vaccina-
tion against these illnesses are historically <45% (11–13). 
We hypothesize that subclinical infection of children with 
hepatitis A or the low likelihood of adults or children with 
mild influenza-like illness to seek medical attention may 
account for low numbers of these 2 VPI reported from Ge-
oSentinel sites. Most hepatitis A cases were in travelers 
to Northern Africa, which reflects the high rate of gastro-
intestinal infections from that region (Table 3). Our find-
ings emphasize the importance of hepatitis A vaccination, 
which should be emphasized to health care providers and 
travelers alike, particularly when Northern Africa is the in-
tended travel destination. 
The high number of animal bites and the subsequent 
need for rabies PEP in travelers returning from Northern 
Africa are likely to reflect bias because 97% of GeoSen-
tinel-reported cases in travelers returning from Northern 
Africa who sought rabies PEP were reported to the Mar-
seille, France, site, which is a reference center for manage-
ment of suspected rabies exposures. However, the paucity 
of reported bites and need for rabies PEP at GeoSentinel 
sites among travelers returning from sub-Saharan Africa 
may in part reflect that travelers to sub-Saharan Africa 
were more often travelers VFR or long-term travelers, who 
may be more likely than tourists to Northern Africa to seek 
treatment at the time of exposure (14).
Sixty-seven percent of the world’s HIV-infected popu-
lation resides in sub-Saharan Africa (15), and tuberculosis 
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Table 3. Diagnoses in descending order of frequency, by region of origin, for ill travelers returning from Africa who were seen at 
GeoSentinel clinic sites, March 1997–May 2011* 
Total, N = 16,893 
Illness and no. (%) travelers 
Central Africa,  
n = 1,547 
Eastern Africa,  
n = 5,516 
Northern Africa,  
n = 2,474 
Southern Africa,  
n = 1,457 
Western Africa,  
n = 5,899 
Malaria, 
Plasmodium 
falciparum. 2,118 
(13) 
Malaria, P. 
falciparum, 313 (20) 
Viral syndrome, no 
rash, 444 (8) 
Diarrhea, acute 
unspecified, 419 (17) 
Rickettsia, tick-borne 
spotted fever, R. 
africae, R. conorii, R. 
rickettsii and other, 
273 (19) 
Malaria, P. 
falciparum, 1,484 
(25) 
Diarrhea, acute 
unspecified, 1,373 
(8) 
Viral syndrome, no 
rash, 114 (7) 
Diarrhea, acute 
unspecified, 414 (8) 
Diarrhea, chronic 
unknown, 262 (11) 
Viral syndrome, no 
rash, 177 (12) 
Viral syndrome, no 
rash, 396 (7) 
Viral syndrome, no 
rash, 1200 (7) 
Filaria, Loa Loa, 81 
(5) 
Malaria, P. 
falciparum, 291 (5) 
Diarrhea, acute 
bacterial, 145 (6) 
Diarrhea, acute 
unspecified, 95 (7) 
Diarrhea, acute 
unspecified, 365 (6) 
Diarrhea, chronic 
unknown, 791 (5) 
Diarrhea, acute 
unspecified, 80 (5) 
Diarrhea, chronic 
unknown, 254 (5) 
Gastroenteritis, 107 
(4) 
Diarrhea, chronic 
unknown 69 (5) 
Giardia, 209 (4) 
Diarrhea, acute 
bacterial, 638 (4) 
Diarrhea, acute 
bacterial, 48 (3) 
Diarrhea, acute 
bacterial, 219 (4) 
Rabies, 
postexposure 
prophylaxis, 107 (4) 
Febrile illness, 
unspecified (<3 wk), 
53 (4) 
Diarrhea, acute 
bacterial, 207 (4) 
Febrile illness, 
unspecified, <3 wk, 
495 (3) 
Febrile illness, 
unspecified, <3 wk, 
46 (3) 
Febrile illness, 
unspecified, <3 wk, 
180 (3) 
Irritable bowel 
syndrome, post 
infectious, 89 (4) 
Respiratory tract 
infection (upper), 40 
(3) 
Febrile illness, 
unspecified, <3 wk, 
184 (3) 
Giardia, 491 (3) Diarrhea, chronic 
unknown, 42 (3) 
Respiratory tract inf 
(upper), 167 (3) 
Giardia, 87 (4) Bite or sting, insect, 33 
(2) 
Diarrhea, chronic 
unknown, 164 (3) 
Respiratory tract 
infection (upper), 
387 (2) 
Giardia, 41 (3) Bite or sting, insect, 
142 (3) 
Viral syndrome, no 
rash, 69 (3) 
Rash, unknown 
etiology (non-febrile), 
33 (2) 
Respiratory tract 
infection (upper), 
124 (2) 
Irritable bowel 
syndrome, post 
infectious, 375 (2) 
Strongyloides, 
simple intestinal, 34 
(2) 
Giardiasis, 133 (2) Bite, dog, 52 (2) Bite, insect; 
superinfected, 25, (2) 
Irritable bowel 
syndrome, post-
infectious, 110 (2) 
Rickettsia, tick-
borne spotted fever, 
336 (2) 
Malaria, severe and 
complicated, 
noncerebral, 27 (2) 
Irritable bowel 
syndrome, post-
infectious, 131 (2) 
Campylobacter, 42 
(2) 
Bite, Tick 23 (2) Malaria, species 
unknown 103 (2) 
*The United Nations geoscheme was used to classify Africa into subregions (5). 
 
RESEARCH
prevalence in some regions of Africa approaches 1% (16). 
Because 5%–50% of travelers report casual sexual experi-
ences while traveling (17), it is surprising that so few cases 
of acute HIV infection were documented in travelers exam-
ined in GeoSentinel sites if risk behavior and endemicity 
of infection are high in many regions (18). Travelers who 
have symptoms of HIV and other sexually transmitted in-
fections may seek care at specialty clinics rather than at Ge-
oSentinel sites. However, because symptoms of acute HIV 
infection are commonly protean, and often manifest as a 
nonspecific febrile illness, travelers are as likely to go to 
GeoSentinel clinic sites as to specialist clinics. HIV should 
always be considered as a differential diagnosis in febrile 
returning travelers or in travelers who have clinical fea-
tures compatible with HIV seroconversion illness. Regard-
ing tuberculosis, although reactivation of latent infection 
may occur many years after acquisition, it is noteworthy 
that despite the large number of tuberculosis cases in most 
regions of sub-Saharan Africa, so few symptomatic cases 
occurred in travelers to Africa during the prolonged period 
of this study.
Previous studies of illnesses acquired by travelers to 
Africa have focused on illnesses acquired from sub-Saharan 
Africa as a whole (2,19), have been conducted at a single 
center (20,21), or have had analyses limited to a single dis-
ease or infection (2,5). Strengths of the current study are data 
capture from 54 international surveillance sites and >500 dif-
ferent diagnoses, enabling us to show regional patterns of 
illness in Africa. In addition, data were collected during an 
extended time period, which may offset acute spikes in re-
porting particular diagnoses that could skew the data.
Conclusions
This study confirms that the likelihood of acquiring a 
specific infection or disease is not homogenous through-
out the African continent. Medical practitioners examining 
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Table 4. Nonmalarial illness among travelers returning from Africa who were seen at GeoSentinel clinic sites, March 1997–May 2011* 
Illness/incident 
No. travelers 
Total 
Region visited before illness 
Central Africa  Eastern Africa  Northern Africa  Southern Africa  Western Africa  
Parasitic infection by helminths       
 Schistosomes 530 42 278 41 22 147 
  Unknown spp. 274 27 129 22 13 83 
  Schistosoma mansoni 147 9 89 14 5 30 
  S. haematobium 118 7 66 5 5 35 
 Filaria       
  Strongyloides 195 34 78 13 6 64 
   Simple intestinal 191 34 78 12 6 61 
   Hyperinfection 4 0 0 1 0 3 
  Non-Strongyloides 140 102 6 1 1 30 
   Loa loa 86 82 1 0 0 3 
   Onchocerca volvulus 21 12 0 0 0 9 
   Other 31 9 4 0 1 17 
   Wucheria bancrofti 4 1 1 1 0 1 
Vaccine-preventable disease 146 9 47 37 7 46 
 Hepatitis A 59 3 14 28 1 13 
 Influenza 24 0 11 4 2 7 
 Measles 5 0 0 1 3 1 
 Typhoid fever† 58 6 22 4 1 25 
Bite wounds‡ 193 5 47 105 11 25 
 Bite wounds necessitating rabies  
 prophylaxis 
184 4 38 107 13 22 
 Source of bite       
  Dog 91 4 17 52 7 11 
  Cat 46 0 8 36 0 2 
  Other¶ 56 1 22 17 4 12 
Dengue (uncomplicated) 113 6 46 5 8 48 
Tuberculosis 86 2 33 16 4 31 
 Pulmonary 43 2 14 14 2 11 
 Extrapulmonary 24 0 13 0 0 11 
 Miliary, disseminated 13 0 4 1 2 6 
 Meningitis 5 0 2 1 0 2 
 Multidrug resistant# 1 0 0 0 0 1 
Acute HIV infection 44 4 21 0 5 14 
*The United Nations geoscheme was used to classify Africa into subregions (5). 
†Salmonella enterica serotype Typhi. 
‡Two travelers returning from  Northern Africa and 2 returning from Southern Africa for whom bite wounds were not registered received rabies 
postexposure prophylaxis. 
¶Other bites: monkey (23 bites); snake (3); rat (2); human, horse, puff adder, rabbit arthropoda, baboon, bat, hamster, leech, mangout, mouse, 
scolopendra, squirrel (1 each), missing data (14). 
#Resistance to rifampin and isoniazid. 
 
 Travel-related Illness, Africa
returning febrile travelers from any region in sub-Saharan 
Africa must consider malaria as the first diagnosis. Howev-
er, febrile patients, particularly those from Southern Africa, 
infrequently have malaria; other illnesses such as rickettsial 
infections are more common and should be strongly sus-
pected. Concern about risk and possible damage to health is 
a determinant of whether a person will travel to a particular 
destination (22), so misconceptions should be corrected. 
However, because outbreaks reported, such as the recent 
reports of dengue virus in Angola (23) and Kenya (24) can 
rapidly alter exposure risk, up-to-date knowledge of pat-
terns of disease is crucial.
During pretravel consultation, prevention of illness 
in travelers to different regions within Africa should be 
prioritized on the basis of the regional profile of diagno-
ses. For Northern Africa, advice should include detailed 
information about food hygiene and rabies prophylaxis. 
For countries in the Southern African region, malaria 
chemoprophylaxis and mosquito bite prevention mea-
sures should be used to prevent malaria acquisition during 
travel to regions in which malaria is endemic. The travel 
medicine advisor should be familiar with malaria-endem-
ic and malaria-free areas in Africa to be able to provide 
suitable recommendations. Special attention should be 
paid to travelers VFR, who are most likely to acquire ma-
laria, and to business travelers, whose malarial infection 
may be more likely to be fatal. Advice about preventing 
tick-borne rickettsial infections is essential for travel-
ers to Southern Africa. Helminthic infections should be 
discussed. Preexposure and postexposure rabies vaccina-
tion, travelers’ diarrhea, and vaccine-preventable diseases 
should be discussed with travelers to destinations on the 
entire African continent.
Our analysis has some limitations: GeoSentinel Sites 
see a subset of all travelers to a particular country or re-
gion, and a main limitation of our study is an inability to 
calculate absolute risk for or true incidence of a disease 
from that country or region. Furthermore, not all returning 
travelers who are ill will seek care at a GeoSentinel site 
but instead will visit infectious diseases specialists, pedia-
tricians, or nonspecialists. Children and adults with mild 
illness, such as an influenza-like illness, may not seek care 
at all. For 16,925 travelers in the GeoSentinel database, 
the name of the country in which they were exposed was 
missing or unascertainable. Of these, 3,364 persons had 
traveled to countries within the same African region and 
nowhere else and were therefore included in the dataset. 
The remaining 13,561 records were excluded from analy-
sis. The effect of this removal of records on introducing 
bias is unknown. However, including them in the analysis 
would have risked including illnesses ascribed to 1 region 
but acquired in another. One GeoSentinel site contributed 
25% of the final dataset, and these travelers were more 
likely to have traveled to Northern Africa (40%), be fe-
male (52%), and be a tourist (36%). Excluding this group 
did not substantially alter the profile of the final dataset. 
Northern Africa is viewed increasingly by European tour-
ists as a Mediterranean-like destination in which risk for 
illness is lower than that in other parts of Africa, which 
may partially explain the low rate of pretravel consulta-
tion for travelers to Northern Africa.
The United Nations geoscheme for dividing Africa 
into 5 constituent regions is limited in that it was originally 
devised to enable statistical analysis of various parameters. 
Therefore, assignment of any 1 country into a particular 
area was for statistical convenience and was not meant 
to imply assumptions regarding health data. Thus, some 
countries, particularly those that border each other but are 
in different regions by the United Nations definition, may 
share health exposure risks for travelers, which therefore 
limits our study’s findings. However, because no division 
of Africa has been performed on health grounds, devising 
an arbitrary regional division would be equally as specula-
tive and open to bias.
In conclusion, our study shows that health risks of 
travel to Africa are not uniform. Geographic profiling of 
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Table 5. Malaria in ill returned travelers from Africa seen at GeoSentinel clinic sites, March 1997–May 2011* 
Illness 
No. (%) travelers 
Total, 
N = 16,893 
Region visited before illness 
Central Africa, 
n = 1,547 
Eastern Africa, 
n = 5,516 
Northern Africa, 
n = 2,474 
Southern Africa, 
n = 1,457 
Western Africa, 
n = 5,899 
Febrile/systemic illness 5,505 (33) 626 (40) 1,474 (27) 219 (9) 579 (23) 2,607 (44) 
Malaria† 2,789 (50.7) 416 (66.5) 515 (34.9) 37 (16.9) 12 (2.1) 1,809 (69.4) 
 Plasmodium falciparum‡ 2,230 (40.5) 338 (54.0) 316 (21.4) 22 (10.0) 9 (1.6) 1,545 (59.3) 
  Uncomplicated 2,118 (38) 313 (50.0) 291 (19.7) 22 (10.0) 8 (1.4) 1,484 (56.9) 
  Severe noncerebral 104 (1.9) 27 (4.3) 23 (1.6) 1 (0.5) 1 (0.2) 52 (2.0) 
  Severe cerebral 61 (1.1) 13 (2.1) 12 (8) 0 1 (0.2) 35 (1.3) 
 P. vivax 197 (3.6) 19 (3.0) 122 (8.3) 9 (4.1) 0 47 (1.8) 
 P.ovale 138 (2.5) 21 (3.4) 26 (1.8) 2 (1) 0 89 (3.4) 
 P.malariae 84 (1.5) 20 (3.2) 17 (1.2) 2 (1) 0 45 (1.7) 
 Unknown species 179 (3.3) 26 (4.2) 44 (3.0) 3 (1.4) 3 (0.5) 103 (4.0) 
*The United Nations geoscheme was used to classify Africa into subregions (5). 
†Sudan and Western Sahara are malaria-endemic countries. 
‡Row totals indicate unique patients. 
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illness acquired during travel to Africa facilitates targeted 
pretravel advice, expedites diagnosis in ill returnees, and 
may influence destination choices in tourism.
Members of the GeoSentinel Surveillance Network who con-
tributed data to this study are: Rahul Anand, University of Utah, 
Salt Lake City, Utah, USA; Hilmir Ásgeirsson, Karolinska Uni-
versity Hospital, Stockholm, Sweden; Elizabeth D. Barnett, Boston 
University, Boston, Massachusetts, USA; Sarah Borwein, Travel-
Safe Medical Centre, Hong Kong SAR, China; Gerd-Dieter Bur-
chard, Bernhard-Nocht-Institute for Tropical Medicine, Hamburg, 
Germany; John D. Cahill, St. Luke’s-Roosevelt Hospital Center, 
New York, New York, USA; Daniel Campion, London InterHealth, 
London, UK; Francesco Castelli, University of Brescia, Brescia, 
Italy; Eric Caumes, Hôpital Pitié-Salpêtrière, Paris, France; Lin H. 
Chen, Mount Auburn Hospital, Harvard University, Cambridge, 
Massachusetts; Bradley A. Connor, Cornell University, New York; 
Christina M. Coyle, Albert Einstein School of Medicine, Bronx, 
New York; Jakob Cramer, Bernhard-Nocht-Institute for Tropical 
Medicine, Hamburg; Jane Eason, Beijing United Family Hospital 
and Clinics, Beijing, China; Cécile Ficko, Hôpital d’instruction 
des armées Bégin, Saint-Mandé, France; Vanessa Field, London 
InterHealth, London; David O. Freedman, University of Alabama 
at Birmingham, Alabama, USA; Abram Goorhuis, University of 
Amsterdam, Amsterdam, the Netherlands; Martin P. Grobusch, 
University of Amsterdam, Amsterdam; Alejandra Gurtman, Mount 
Sinai Medical Center, New York; Devon C. Hale, University of 
Utah, Salt Lake City, Utah, USA; Annemarie Hern, Worldwise 
Travellers Health and Vaccination Centre, Auckland, New Zea-
land; Noreen Hynes, Johns Hopkins University, Baltimore, Mary-
land, USA; Mogens Jensenius, Oslo University Hospital, Oslo, 
Norway; Robert Kass, Travellers Medical and Vaccination Centres 
of Australia, Adelaide, Australia; Amy D. Klion, National Insti-
tutes of Health, Bethesda, Maryland; Phyllis E. Kozarsky, Emory 
University, Atlanta, Georgia, USA; Karin Leder, Royal Melbourne 
Hospital, Melbourne, Australia; Carmelo Licitra, Orlando Regional 
Health Center, Orlando, Florida, USA; Rogelio López-Vélez, Hos-
pital Ramon y Cajal, Madrid, Spain; Michael W. Lynch, Fresno 
International Travel Medical Center, Fresno, California, USA; 
Alberto Matteelli, University of Brescia; Anne McCarthy, Uni-
versity of Ottawa, Ottawa, Canada; George McKinley, St. Luke’s-
Roosevelt Hospital Center, New York; Susan McLellan; Tulane 
University, New Orleans, Louisiana, USA; José Antonio Pérez 
Molina, Hospital Ramon y Cajal; Robert Muller, Travel Clinic Ser-
vices, Johannesburg, South Africa; Thomas B. Nutman, National 
Institutes of Health; Alice Pérignon, Hôpital Pitié-Salpêtrière; Phi 
Truong Hoang Phu, International SOS Clinic, Ho Chi Minh City, 
Vietnam; Watcharapong Piyaphanee, Mahidol University, Bang-
kok, Thailand; Christophe Rapp, Hôpital d’instruction des armées 
Bégin, Saint-Mandé, France; David Roesel, University of Wash-
ington and Harborview Medical Center, Seattle, Washington, USA; 
Eli Schwartz, Chaim Sheba Medical Center, Tel Hashomer, Israel; 
Marc Shaw, Worldwise Travellers Health and Vaccination Centre, 
Auckland; Udomsak Silachamroon, Mahidol University; William 
Stauffer, Regions Hospital, St. Paul, Minnesota, USA; Natsuo 
Tachikawa, Yokohama Municipal Citizen’s Hospital, Yokohama, 
Japan; Joseph Torresi, Royal Melbourne Hospital; Johan Ursing, 
Karolinska University Hospital; Jean Vincelette, Centre Hospital-
ier de l’Université de Montréal, Montréal, Québec, Canada; Patri-
cia Walker, HealthPartners, St. Paul; Andy Wang, Beijing United 
Family Hospital and Clinics; Mary E. Wilson, Harvard University; 
Henry Wu, Emory University; Yukihiro Yoshimura, Yokohama 
Municipal Citizen’s Hospital.
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